Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules

Pharma/BioPharma |  News | 0 Comment | 17 Jun, 2019

Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the USFDA to market Omega-3-Acid Ethyl Esters Capsules USP (US RLD &ndash...Read more

Sun Pharma’s ILUMYA improves joint and skin symptoms of Psoriatic Arthritis

Pharma/BioPharma |  News | 0 Comment | 14 Jun, 2019

Sun Pharmaceutical Industries Ltd. recently announced interim results from a Phase 2 study of interleukin-23 (IL-23) inhibitor ILUMYA™ (tildrakizumab-asmn) in patients with activ...Read more

IPHEX 2019 mega pharma show opens in Gandhinagar

Pharma/BioPharma |  News | 0 Comment | 10 Jun, 2019

Gujarat is set to be the Hub of Indian Pharma Sector. Speaking at the inauguration, Gujarat Chief Minister, Shri Vijay Rupani welcomed over 650 overseas pharma buyers and Government delegat...Read more

PharmaLytica 2019 set for an impressive debut in Mumbai

Pharma/BioPharma |  News | 0 Comment | 10 Jun, 2019

UBM India, organizers of CPhI / P-MEC India, the leading global pharma trade show and conference, has announced the 6th edition of the PharmaLytica expo. Formerly a two-day event, Pharmalyt...Read more

Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2)

Pharma/BioPharma |  News | 0 Comment | 05 Jun, 2019

Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep facility (Unit-2), by the Pharmaceutical and Medical Devices Agency (PM...Read more

Dr. Reddy's announces the re-launch of Zenatane

Pharma/BioPharma |  News | 0 Comment | 06 Jun, 2019

Dr. Reddy’s Laboratories has announced the relaunch of Zenatane® (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg a therapeutic equivalent generic version of Accutane&r...Read more

PHARMEXCIL to host IPHEX 2019 in Gujarat

Pharma/BioPharma |  News | 0 Comment | 04 Jun, 2019

Bridging the gap between the global pharmaceutical procurement agencies and the small and medium scale sellers in the Indian market, the Pharmaceuticals Export Promotion Council of India (P...Read more

AstraZeneca expands clinical research operations in India

Pharma/BioPharma |  News | 0 Comment | 30 May, 2019

Global science-led biopharmaceutical company, AstraZeneca officially announces the expansion of its clinical research operations in India with the launch of a new dedicated unit in Bengalur...Read more

Indian e-pharma market poised to touch US$2.7 billion by 2023: EY

Pharma/BioPharma |  News | 0 Comment | 29 May, 2019

According to a new EY report ‘e-pharma: delivering healthier outcomes’, e-pharma players are expected to attain a combined market size of US$2.7 billion by 2023 from about US$36...Read more

Glenmark receives ANDA approval for Aspirin and generic version of Aggrenox® Capsules

Pharma/BioPharma |  News | 0 Comment | 27 May, 2019

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg,...Read more

8th Annual InnoPack Pharma Confex engages industry audience

Pharma/BioPharma |  News | 0 Comment | 23 May, 2019

CPhI Conferences, a division of UBM India, which hosts a number of successful pharmaceutical conferences announced the 8th Annual InnoPack Pharma Confex slated for 21 - 22 Ma...Read more

Glenmark receives ANDA approval for generic version of Vesicare® Tablets

Pharma/BioPharma |  News | 0 Comment | 21 May, 2019

Glenmark Pharmaceuticals has been granted final approval by the USFDA for Solifenacin Succinate Tablets, 5 mg and 10 mg, a generic version of Vesicare® Tablets, 5 mg and 10 mg, of Astel...Read more

Drug Control Lab functional at Bengaluru airport

Pharma/BioPharma |  News | 0 Comment | 13 May, 2019

The Kempegowda International Airport, Bengaluru (BLR Airport) – operated by Bangalore International Airport Ltd. (BIAL) now has a fully functional Drug Control Lab. “We are the...Read more

Lupin launches Clobazam tablets

Pharma/BioPharma |  News | 0 Comment | 10 May, 2019

Pharma major Lupin Limited (Lupin) announced the launch of Clobazam Tablets, 10 mg and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.&...Read more

Glenmark announces results from a Phase 3 Study of Ryaltris™

Pharma/BioPharma |  News | 0 Comment | 09 May, 2019

Glenmark Pharmaceuticals has announced positive results from a Phase 3 study of Ryaltris, an investigational fixed-dose combination nasal spray for the treatment of seasonal allergic rhinit...Read more

Lupin receives tentative USFDA approval for Fosaprepitant for Injection

Pharma/BioPharma |  News | 0 Comment | 08 May, 2019

Lupin Limited (Lupin) has received tentative approval for its Fosaprepitant for Injection, 150 mg Single-Dose Vial, from the United States Food and Drug Administration (FDA) to market a gen...Read more

Alembic gets USFDA nod for Olopatadine Hydrochloride Ophthalmic Solution

Pharma/BioPharma |  News | 0 Comment | 08 May, 2019

Alembic Pharmaceuticals Limited recently announced that the Company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) ...Read more

USFDA classifies Strides Puducherry facility as Official Action Initiated (OAI)

Pharma/BioPharma |  News | 0 Comment | 06 May, 2019

Strides Pharma Science ltd. has received a communication from the US Food and Drug Administration (USFDA) on May 4, 2019, classifying the facility as OAI based on the inspection c...Read more